FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome

The U.S. Food and Drug Administration has approved Onfi (clobazam) for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here